SCHEMBL7140345

SCHEMBL7140345

Cc1nc(NC(=N)NCc2ccccc2)sc1-c1cccc([N+](=O)[O-])c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
ACKR3 P25106 1/20 0.48
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 3/20 0.46
POLB P06746 2/20 0.46
LMNA P02545 1/20 0.44
MCL1 Q07820 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CFTR P13569 2/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.42
F2 P00734 1/20 0.42
HTT P42858 1/20 0.42
ALOX5 P09917 1/20 0.42
ATG4B Q9Y4P1 1/20 0.41
LCK P06239 1/20 0.41
THRB P10828 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144160 0.89 MAPT (0.53) MAPTACKR3MEN1KMT2AMAPK1
SCHEMBL7139996 0.83 CFTR (0.45) MAPTMEN1KMT2AALDH1A1LMNA
SCHEMBL3598571 0.81 MEN1 (0.52) MAPTMEN1KMT2AMAPK1ALDH1A1
Iodide SCHEMBL7146780 0.80 MEN1 (0.48) MAPTMEN1KMT2AMAPK1ALDH1A1
SCHEMBL48503 0.79 MEN1 (0.65) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL48750 0.79 MAPT (0.50) MAPTMEN1KMT2AMAPK1ALDH1A1
SCHEMBL7140350 0.78 MAPT (0.48) MAPTACKR3MEN1KMT2AMAPK1
SCHEMBL7142259 0.77 MEN1 (0.52) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL7144161 0.76 ATG4B (0.53) MAPTACKR3MEN1KMT2AMAPK1
SCHEMBL7145860 0.75 CFTR (0.41) MAPTMEN1KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0928790-B1 Thiazole derivatives HOFFMANN LA ROCHE (CH) 2003-03-05 EP disclosed
US-6344562-B1 ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. 2002-02-05 US disclosed
US-20020010316-A1 Thiazole derivatives ALIG LEO (CH) 2002-01-24 US disclosed
US-6320054-B1 INHIBIT BINDING OF ADHESIVE PROTEINS TO THE SURFACE OF DIFFERENT TYPES F CELL AND ACCORDINGLY INFLUENCE CELL-CELL AND CELL-MATRIX INTERACTIONS. HOFFMAN-LA ROCHE INC. 2001-11-20 US disclosed
US-6100282-A Thiazole derivatives HOFFMAN-LA ROCHE INC. (US) 2000-08-08 US disclosed
EP-0928790-A1 Thiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010316-A1 Thiazole derivatives VCAM1, SOST, TGFB1 MAPT 86/4885ACKR3 270/4885MEN1 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.